Medical management of RA patients with pericarditis
| Medical management |
|---|
| Prednisone 0.3–0.5 mg/kg per day taped over 2–4 weeks |
| MTX up to 20 mg per oral (PO) or subcutaneous (SQ) weekly |
| Leflunomide up to 20 mg daily PO |
| Optimization of DMARDs |
Medical management of RA patients with pericarditis
| Medical management |
|---|
| Prednisone 0.3–0.5 mg/kg per day taped over 2–4 weeks |
| MTX up to 20 mg per oral (PO) or subcutaneous (SQ) weekly |
| Leflunomide up to 20 mg daily PO |
| Optimization of DMARDs |
UÖ, NK, and MG: Conceptualization, Investigation, Writing—original draft, Writing—review & editing. NT and MB: Validation, Writing—review & editing, Supervision. All authors read and approved the submitted version.
The authors declare that they have no conflicts of interest.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
© The Author(s) 2023.